cyclin-dependent kinase inhibitor 1B
| GO Term | Evidence Code | PMID |
|---|---|---|
| regulation of cyclin-dependent protein serine/threonine kinase activity | ||
| G1/S transition of mitotic cell cycle | ||
| G1/S transition of mitotic cell cycle | ||
| response to hypoxia | ||
| placenta development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| nucleus | ||
| nucleus | ||
| nucleoplasm | ||
| nucleoplasm | ||
| cytoplasm |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein kinase inhibitor activity | ||
| cyclin-dependent protein serine/threonine kinase inhibitor activity | ||
| cyclin-dependent protein serine/threonine kinase inhibitor activity | ||
| protein binding | ||
| protein kinase binding |
| Location | References |
|---|---|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050771 | pheochromocytoma | |
| DOID:0050773 | paraganglioma | |
| DOID:3125 | multiple endocrine neoplasia | |
| DOID:3829 | pituitary adenoma | |
| DOID:5223 | infertility | |
| DOID:5844 | myocardial infarction | |
| DOID:83 | cataract |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026